Cencora, Inc. COR

306.92 (2.95) (0.95%) as of 25 Sep
Market cap
$59.1B
P/E
22.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Cencora, Inc. (COR) Gross margin

Cencora, Inc.'s gross margin over the twelve months to 30 June 2026 was 3.97%, up 0.4 percentage points from fiscal 2025 (3.57%). Over the past ten years it has ranged from 2.60% (fiscal 2015) to 3.57% (fiscal 2025) — the current reading is the highest in ten years. That is below the Medical Distribution industry median of 8.01% and below the Healthcare sector median of 53.7%.

Gross margin, annual

Annual

Period Gross margin Change (points)
FY2025 3.57% 0.20
FY2024 3.37% (0.05)
FY2023 3.42% (0.06)
FY2022 3.48% 0.24
FY2021 3.24% 0.51
FY2020 2.73% (0.13)
FY2019 2.86% 0.11
FY2018 2.75% (0.22)
FY2017 2.97% 0.06
FY2016 2.91% 0.31

Quarterly

Period Gross margin Change (points)
Jun 2026 4.26% (0.32)
Mar 2026 4.58% 1.00
Dec 2025 3.58% 0.05
Sep 2025 3.53% (0.07)
42 more quarters

Against its own ten years

Low 2.60% High 3.57%
Ten-year median 2.97%
Current reading's percentile 100

Gross margin against peers

Company Gross margin
ACH Accendra Health, Inc. compare 44.8%
FOCL FocalTherics compare 44.5%
HSIC Henry Schein, Inc. compare 31.3%
COSM Cosmos Health Inc. compare 10.3%
YI 111, Inc. Sponsored ADR compare 5.74%
COR Cencora, Inc. 3.97%
CAH Cardinal Health, Inc. compare 3.84%
MCK McKesson Corporation compare 3.64%
AHG Akso Health Group Sponsored ADR compare 0.00%
Medical Distribution industry median 8.01%
Healthcare sector median 53.7%
Market median 46.3%

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on COR